JFG
DNTH icon

Jefferies Financial Group’s Dianthus Therapeutics DNTH Stock Holding History

Jefferies Financial Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Buy
+202,410
New +$11.7M 0.12% 146
2024
Q2 		– Sell
-7,600
Closed -$228K – 1518
2024
Q1 		$228K Sell
7,600
-5,600
-42% -$122K ﹤0.01% 1304
2023
Q4 		$137K Hold
13,200
– – ﹤0.01% 1515
2023
Q3 		$180K Buy
+13,200
New +$166K ﹤0.01% 1364

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Financial Group's DNTH Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in Dianthus Therapeutics (DNTH) in Q1 2026: 202,410 shares worth $17M. The stake represents 0.12% of the portfolio and ranks #146 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in DNTH as recently as Q1 2024.

Jefferies Financial Group first reported a position in DNTH in Q3 2023 and has held it in 4 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Jefferies Financial Group held 202,410 shares of Dianthus Therapeutics worth $17M as of Q1 2026.
  • Dianthus Therapeutics was a new Jefferies Financial Group position in Q1 2026.
  • Dianthus Therapeutics made up 0.12% of Jefferies Financial Group's portfolio in Q1 2026, its #146 holding.
  • Jefferies Financial Group first reported a position in Dianthus Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.